Establishment of a scoring model for predicting clinical outcomes in patients with unilateral primary aldosteronism after superselective adrenal artery embolization-Reference-Cited by-同舟云学术

Establishment of a scoring model for predicting clinical outcomes in patients with unilateral primary aldosteronism after superselective adrenal artery embolization

Published:2024-06-10 Issue: Volume: Page:
ISSN:0021-1265
Container-title:Irish Journal of Medical Science (1971 -)
language:en
Short-container-title:Ir J Med Sci

Author:

Luo Tao,Wan Jindong,Liu Sen,Wang Xinquan,Zhou Peng,Xue Qiang,Hou Jixin,Wang Peijian^ORCID

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s11845-024-03730-5.pdf

Reference38 articles.

1. Turcu AF, Yang J, Vaidya A (2022) Primary aldosteronism-a multidimensional syndrome. Nat Rev Endocrinol 18(11):665–682. https://doi.org/10.1038/s41574-022-00730-2

2. Naito T, Inoue K, Sonehara K et al (2023) Genetic risk of primary aldosteronism and its contribution to hypertension: a cross-ancestry meta-analysis of genome-wide association studies. Circulation 147(14):1097–1109. https://doi.org/10.1161/CIRCULATIONAHA.122.062349

3. Funder JW, Carey RM (2022) Primary aldosteronism: where are we now? where to from here? Hypertension 79(4):726–735. https://doi.org/10.1161/HYPERTENSIONAHA.121.18761

4. Mulatero P, Monticone S, Deinum J et al (2020) Genetics, prevalence, screening and confirmation of primary aldosteronism: a position statement and consensus of the Working Group on Endocrine Hypertension of The European Society of Hypertension. J Hypertens 38(10):1919–1928. https://doi.org/10.1097/HJH.0000000000002510

5. Cohen JB, Bancos I, Brown JM et al (2023) Primary aldosteronism and the role of mineralocorticoid receptor antagonists for the heart and kidneys. Annu Rev Med 74:217–230. https://doi.org/10.1146/annurev-med-042921-100438